Outcomes of venetoclax-based therapy in chronic phase and blast transformed chronic myelomonocytic leukemia

Antoine N. Saliba; Mark R. Litzow; Naseema Gangat; Aref Al-Kali; James M. Foran; William J. Hogan; Jeanne M. Palmer; Abhishek A. Mangaonkar; Ayalew Tefferi; Mrinal M. Patnaik

doi:10.1002/ajh.26334

Outcomes of venetoclax-based therapy in chronic phase and blast transformed chronic myelomonocytic leukemia

Antoine N. Saliba, Mark R. Litzow, Naseema Gangat, Aref Al-Kali, James M. Foran, William J. Hogan, Jeanne M. Palmer, Abhishek A. Mangaonkar, Ayalew Tefferi, Mrinal M. Patnaik

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	E433-E436
Journal	American journal of hematology
Volume	96
Issue number	11
DOIs	https://doi.org/10.1002/ajh.26334
State	Published - Nov 1 2021

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.26334

Cite this

@article{54aec71ddf8e434aa5d4fdfd1a148700,

title = "Outcomes of venetoclax-based therapy in chronic phase and blast transformed chronic myelomonocytic leukemia",

author = "Saliba, {Antoine N.} and Litzow, {Mark R.} and Naseema Gangat and Aref Al-Kali and Foran, {James M.} and Hogan, {William J.} and Palmer, {Jeanne M.} and Mangaonkar, {Abhishek A.} and Ayalew Tefferi and Patnaik, {Mrinal M.}",

note = "Funding Information: The authors acknolwedge the contributions of Zhuoer Xie, MD, MS, Evandro D. Bezerra, MD, Paul J. Hampel, MD, Caleb J. Scheckel, DO, Hassan Alkhateeb, MD, Mohamed A. Kharfan Dabaja, MD, MBA, Kebede H. Begna, MD, Sikander Ailawadhi, MD, Mithun V. Shah, MD, PhD, James L. Slack, MD, and Kristin McCullough, PharmD, RPh.",

year = "2021",

month = nov,

day = "1",

doi = "10.1002/ajh.26334",

language = "English (US)",

volume = "96",

pages = "E433--E436",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "11",

}

TY - JOUR

T1 - Outcomes of venetoclax-based therapy in chronic phase and blast transformed chronic myelomonocytic leukemia

AU - Saliba, Antoine N.

AU - Litzow, Mark R.

AU - Gangat, Naseema

AU - Al-Kali, Aref

AU - Foran, James M.

AU - Hogan, William J.

AU - Palmer, Jeanne M.

AU - Mangaonkar, Abhishek A.

AU - Tefferi, Ayalew

AU - Patnaik, Mrinal M.

N1 - Funding Information: The authors acknolwedge the contributions of Zhuoer Xie, MD, MS, Evandro D. Bezerra, MD, Paul J. Hampel, MD, Caleb J. Scheckel, DO, Hassan Alkhateeb, MD, Mohamed A. Kharfan Dabaja, MD, MBA, Kebede H. Begna, MD, Sikander Ailawadhi, MD, Mithun V. Shah, MD, PhD, James L. Slack, MD, and Kristin McCullough, PharmD, RPh.

PY - 2021/11/1

Y1 - 2021/11/1

UR - http://www.scopus.com/inward/record.url?scp=85114674909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85114674909&partnerID=8YFLogxK

U2 - 10.1002/ajh.26334

DO - 10.1002/ajh.26334

M3 - Letter

C2 - 34428328

AN - SCOPUS:85114674909

SN - 0361-8609

VL - 96

SP - E433-E436

JO - American journal of hematology

JF - American journal of hematology

IS - 11

ER -

Outcomes of venetoclax-based therapy in chronic phase and blast transformed chronic myelomonocytic leukemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this